Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-06-24A Phase I Trial of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-AAG, NSC #330507) Daily X 5 in Patients With Advanced Cancer Therapeutic Protocol
-
CLINICAL_TRIALS study record update · 2013-06-24A Phase II Trial of ZD1839 (Iressa) (NSC# 715055) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma
-
CLINICAL_TRIALS study record update · 2013-06-24Myeloablative Chemotherapy With Bone Marrow Rescue For Rare Poor-Prognosis Cancers
-
CLINICAL_TRIALS study record update · 2013-06-24A Phase II Study of BMS-247550 In Advanced Germ Cell Tumor Patients - THERAPEUTIC/DIAGNOSTIC PROTOCOL
-
CLINICAL_TRIALS study record update · 2013-06-21Phase II Trial of Cisplatin and Irinotecan in Patients With Suboptimally Debulked, Incompletely Responding Ovarian Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-06-21Evaluation of Aminocamptothecin (9-AC, NSC #603071) in Recurrent, Platinum Resistant and Refractory Ovarian Cancer and Primary Peritoneal Carcinoma
-
CLINICAL_TRIALS study record update · 2013-06-21Phase II Evaluation of Oxaliplatin in Recurrent, Platinum Resistant and Refractory Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2013-06-20Vaccine Therapy With Tumor Specific p53 Peptides in Adult Patients With Adenocarcinoma of the Breast or Ovary
-
CLINICAL_TRIALS study record update · 2013-06-20A Phase II Study of MGI-114 in Patients With Recurrent or Persistent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2013-06-20Phase II Pilot Study of Clinical Activity and Proteomic Pathway Profiling of the EGFR Inhibitor, ZD1839 (Iressa; Gefitinib), in Patients With Epithelial Ovarian Cancer or Cervical Cancer
-
CLINICAL_TRIALS study record update · 2013-06-20VACCINE THERAPY WITH TUMOR SPECIFIC MUTATED P53 OR RAS PEPTIDES ALONE OR IN COMBINATION WITH CELLULAR IMMUNOTHERAPY WITH PEPTIDE ACTIVATED LYMPHOCYTES (PAL CELLS) ALONG WITH SUBCUTANEOUS IL-2
-
CLINICAL_TRIALS study record update · 2013-06-20A Phase II Trial of Orally Administered CAI for Patients With Persistent or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2013-06-20A Phase I/II Trial of Temodar in Pediatric Patients and Young Adults With High-Risk or Recurrent Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-06-19Vaccination of Patients Who Have Ovarian, Fallopian Tube or Peritoneal Cancer With Glycosylated MUC-1-KLH Conjugate Plus the Immunological Adjuvant QS-21
-
CLINICAL_TRIALS study record update · 2013-06-18A Phase II Trial Of Oral Bicalutamide With Subcutaneous Goserelin In Patients With Epithelial Ovarian, Fallopian Tube, Or Peritoneal Carcinoma In Second Or Greater Remission
-
CLINICAL_TRIALS study record update · 2013-06-18Phase II Trial of Thalidomide in Patients With Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2013-06-18Phase I Trial of Taurolidine After Positive Second Look Surgery for Recurrent Ovarian Epithelial, Fallopian Tube and Primary Peritoneal Cancers
-
CLINICAL_TRIALS study record update · 2013-06-12TEACH Survey (Thrombo-Embolism And Chemotherapy) A Prospective Survey on the Incidence of Venous Thromboembolic Events During Chemotherapy for Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-06-10Assessing Economic Outcomes in Women With Stage III Ovarian Cancer Treated With Intravenous Paclitaxel and Cisplatin v. Intravenous Paclitaxel, Intraperitoneal Cisplatin and Intraperitoneal Paclitaxel on GOG #172: A Feasibility Study of Assessing Costs and Medical Resource Use
-
CLINICAL_TRIALS study record update · 2013-06-10Ovarian Cancer Screening Pilot Trial in High Risk Women
-
CLINICAL_TRIALS study record update · 2013-06-10A Phase II Trial of Intravenous Gemcitabine (NSC #613327) and Intraperitoneal Carboplatin (NSC # 241240) in the Treatment of Patients With Platinum-Sensitive Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma With Non-Measurable Disease
-
CLINICAL_TRIALS study record update · 2013-06-10A Phase I Study of Gemcitabine/Topotecan in Combination in Refractory Ovarian Cancer or Cancer of the Fallopian Tube
-
CLINICAL_TRIALS study record update · 2013-06-10Quality of Life in Ovarian Germ Cell Cancer Survivors
-
CLINICAL_TRIALS study record update · 2013-06-10An Exploratory Evaluation of Fenretinide (4-HPR) as a Chemopreventive Agent for Ovarian Carcinoma
-
CLINICAL_TRIALS study record update · 2013-06-10Phase II Study of Prolonged Oral VP-16 for Advanced Ovarian Epithelial and Cervical Cancer